Ene I. Ette is President and CEO of Anoixis Corporation. Experience in academia, drug evaluation and regulation, and the pharmaceutical industry. He has a Ph.D. in Clinical Pharmacology, an …

Pharmacology‬ - ‪Drug development‬ - ‪Design & Analysis of Clinical trials‬.

Dr. Ette has over 30 years of broad experience in academia, drug evaluation and regulation, and the pharmaceutical industry where he held several senior positions, including senior director …

ENE I. ETTE, PhD, is a Fellow of the American Colleges of Clinical Pharmacy and Clinical Pharmacology. He is the President/CEO of Anoixis Corp. and was formerly the senior director …

2007年4月6日 · Ette was a pioneer pharmacometric staff in the Office of Clinical Pharmacology and Biopharmaceutics at the Food and Drug Administration, where he developed the popular …

Importance: Plinabulin is a novel, non-granulocyte colony-stimulating factor (GCSF) small molecule with both anticancer and neutropenia-prevention effects. Objective: To assess the …

2023年10月9日 · Dr. Ette is an accomplished clinical pharmacist, outstanding clinical pharmacologist, pharmacometrician, and drug developer. He is an inventor/co-inventor with …

Dr. Ette, PhD has over 30 years of broad experience in academia, drug evaluation and regulation, and the pharmaceutical industry where he held several senior positions, including senior …

View Ene Ette’s profile on LinkedIn, the world’s largest professional community. Ene has 1 job listed on their profile.

Ene Ette, President, Anoixis Corporation;University of Rhode Island’s College of Pharmacy, Dr. Ette is a fellow of the American Colleges of Clinical Pharmacology, Clinical Pharmacy, and …